Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Timothy Barberich Insider Profile
4 Followers
Timothy Barberich, Director at Novus Therapeutics, holds 121.08K shares in Novus Therapeutics (Ticker: NVUS), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in GI Dynamics Shs Chess Depository Interests repr 02 Shs (Ticker: GIDYL).
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-12.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Timothy Barberich holds in companies
Most Profitable Insider Trade
The most profitable trade made by Timothy Barberich
Timothy Barberich's Trading History
Novus Therapeutics
Sep 24, 2014
Director
Uninformative Buy
―
$3.06M
Rocket Pharmaceuticals
―
Director
―
―
GI Dynamics Shs Chess Depository Interests repr 02 Shs
―
Director
―
―
Frequency Therapeutics
―
Director
―
$5.25M
HeartWare International
Aug 24, 2016
―
Uninformative Sell
644.21K
$556.82K
Verastem
Mar 19, 2019
Director
Informative Buy
105.93K
$334.32K
DARA Biosciences
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Timothy Barberich's performance on stock
You May Also Like
Timothy Barberich insider profile FAQ
What is the percentage of profitable transactions made by Timothy Barberich?
The percentage of profitable transactions made by Timothy Barberich is 43%.
What is the average return per transaction made by Timothy Barberich?
The average return per transaction made by Timothy Barberich is -12.00%.
What stocks does Timothy Barberich hold?
Timothy Barberich holds: NVUS, RCKT, GIDYL, FREQ, HTWR, VSTM, DARA stocks.
What was Timothy Barberich’s latest transaction?
Timothy Barberich latest transaction was an Uninformative Buy of ―.
What was Timothy Barberich's most profitable transaction?
Timothy Barberich’s most profitable transaction was an Informative Buy of VSTM stock on May 17, 2017. The return on the trade was 112.00%.
What is Timothy Barberich's role in Novus Therapeutics?
Timothy Barberich's role in Novus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.